The Medicines Company (MDCO) said that it has filed lawsuits against Teva Parenteral Medicines, Inc., Pliva Hrvatska d.o.o. and APP Pharmaceuticals, LLC, and related entities, alleging patent infringement based on Abbreviated New Drug Applications seeking U.S. FDA approval to market and sell generic versions of the company's Angiomax product prior to patent expiration.
The lawsuit was filed in the District Court of Delaware. The patent was issued to The Medicines Company on September 1, 2009.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.